27 minutes ago
This phase 2b study on brensocatib did not meet its primary or secondary efficacy endpoints, causing Insmed to discontinue their HS program.
32 minutes ago
Panelists discuss the often misdiagnosed neurological and psychiatric manifestations of Wilson disease, highlighting its overlap with common movement and mental health disorders, the need for high clinical suspicion, and the importance of early diagnosis through careful evaluation of overlapping symptoms.
37 minutes ago
Panelists discuss the often subtle and asymptomatic hepatic presentations of Wilson disease, emphasizing the importance of early detection, awareness of advanced complications, and maintaining clinical suspicion to prevent progression to severe liver outcomes.
1 hour ago
Wescott discusses ADAA 2026 findings linking sleeping less than usual to next-day depression in high-risk youth, with interpersonal reactivity emerging as a potential mechanism.
1 hour ago
A DUPLEX study investigator explains the data behind sparsentan's approval by the FDA.